Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

A Novel Oral GyrB/ParE Dual Binding Inhibitor Effective against Multidrug-Resistant Neisseria gonorrhoeae and Other High-Threat Pathogens

Antimicrobial Agents and Chemotherapy(2022)10.1128/aac.00414-22Source: DataRank Database

A Novel Oral GyrB/ParE Dual Binding Inhibitor Effective against Multidrug-Resistant Neisseria gonorrhoeae and Other High-Threat Pathogens is a research paper published in Antimicrobial Agents and Chemotherapy (2022). On theSindex it has a DataRank of 0. It has been cited 10 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access10 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 1.26)OA: hybridTopics (49)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (17)

Riccardo Russo ORCID,Landon Westfall,Riju Shrestha,Matthew Zimmerman ORCID,Véronique Dartois ORCID

Live enrichment

PubMed:35972242 PMC:PMC9487510 OpenAlex:https://openalex.org/W4291964153

HHS | National Institutes of Health

Grant: U19AI109713

National Institutes of Health

Grant: 7U19AI109713-06

Center to develop therapeutic countermeasures to high-threat bacterial agents

FWCI

1.26

Citation Percentile

0.8%

Citation Trend

2023

2024

2025

hybridLicense: cc-by

journalhttps://doi.org/10.1128/aac.00414-22

publisherhttps://doi.org/10.1128/aac.00414-22

publisherhttps://journals.asm.org/doi/pdf/10.1128/aac.00414-22

repositoryhttps://pubmed.ncbi.nlm.nih.gov/35972242

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9487510

Fields of Study

Reproductive tract infections researchBacterial Infections and VaccinesAmoebic Infections and Treatments0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

Adenosine TriphosphateMethanolAnimalsAnti-Bacterial AgentsFemaleGonorrheaMicrobial Sensitivity TestsNeisseria gonorrhoeaePhosphatesProdrugsDrug Resistance, BacterialDNA GyraseMethicillin-Resistant Staphylococcus aureusTopoisomerase II Inhibitors

Keywords

Neisseria gonorrhoeaeMicrobiologyNeisseriaceaeMultiple drug resistanceVirologyNeisseriaBiologyMedicineAntibioticsBacteriaGeneticsTopoisomeraseGyraseC. DifficileVrsaMethicillin-Resistant Staphylococcus aureusMethanolMicrobial Sensitivity TestsAnti-Bacterial AgentsPhosphatesGonorrheaAdenosine TriphosphateDNA GyraseDrug Resistance, BacterialAnimalsTopoisomerase II InhibitorsExperimental TherapeuticsFemaleProdrugs

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being